Kahweol Found in Coffee Inhibits IL-2 Production Via Suppressing the Phosphorylations of ERK and c-Fos in Lymphocytic Jurkat Cells

References

• Abbas AK, Trotta E, R Simeonov D, Marson A, Bluestone JA. 2018. Revisiting IL-2: Biology and therapeutic prospects. Sci Immunol. 3(25):eaat1482. doi:10.1126/sciimmunol.
   PubMed Web of Science ®Google Scholar
• Atif M, Warner S, Oo YH. 2018. Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells. Hepatol Int. 12(4):305–314. doi:10.1007/s12072-018-9882-x.
   PubMed Web of Science ®Google Scholar
• Babova O, Occhipinti A, Maffei ME. 2016. Chemical partitioning and antioxidant capacity of green coffee (Coffea arabica and Coffea canephora) of different geographical origin. Phytochemistry. 123:33–39. doi:10.1016/j.phytochem.2016.01.016.
   PubMed Web of Science ®Google Scholar
• Butt MS, Sultan MT. 2011. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 51(4):363–373. doi:10.1080/10408390903586412.
   PubMed Web of Science ®Google Scholar
• Caprioli G, Cortese M, Maggi F, Minnetti C, Odello L, Sagratini G, Vittori S. 2014. Quantification of caffeine, trigonelline and nicotinic acid in espresso coffee: the influence of espresso machines and coffee cultivars. Int J Food Sci Nutr. 65(4):465–469. doi:10.3109/09637486.2013.873890.
   PubMed Web of Science ®Google Scholar
• Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. 2002. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol. 40(8):1155–1163. doi:10.1016/S0278-6915(02)00029-7.
   PubMed Web of Science ®Google Scholar
• Gross G, Jaccaud E, Huggett AC. 1997. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol. 35(6):547–554. doi:10.1016/S0278-6915(96)00123-8.
   PubMed Web of Science ®Google Scholar
• Gupta S, Cerosaletti K, Long SA. 2014. Renegade homeostatic cytokine responses in T1D: drivers of regulatory/effector T cell imbalance. Clin Immunol. 151(2):146–154. doi:10.1016/j.clim.2014.02.007.
   PubMed Web of Science ®Google Scholar
• Islam MT, Tabrez S, Jabir NR, Ali M, Kamal MA, da Silva Araujo L, De Oliveira Santos JV, Da Mata A, De Aguiar RPS, de Carvalho Melo Cavalcante AA. 2018. An Insight into the Therapeutic Potential of Major Coffee Components. Curr Drug Metab. 19(6):544–556. doi:10.2174/1389200219666180302154551.
   PubMed Web of Science ®Google Scholar
• Jeffery HC, Jeffery LE, Lutz P, Corrigan M, Webb GJ, Hirschfield GM, Adams DH, Oo YH. 2017. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 188(3):394–411. doi:10.1111/cei.12940.
   PubMed Web of Science ®Google Scholar
• Matsuoka K-i, Koreth J, Kim HT, Bascug G, McDonough S, Kawano Y, Murase K, Cutler C, Ho VT, Alyea EP, et al. 2013 . Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Sci Transl Med. 5(179):179ra43. doi:10.1126/scitranslmed.3005265.
   PubMed Web of Science ®Google Scholar
• Miyazaki I, Isooka N, Wada K, Kikuoka R, Kitamura Y, Asanuma M. 2019. Effects of enteric environmental modification by coffee components on neurodegeneration in rotenone-treated mice. Cells. 8(3):221. doi:10.3390/cells8030221.
   Web of Science ®Google Scholar
• Muriel P, Arauz J. 2010. Coffee and liver diseases. Fitoterapia. 81(5):297–305. doi:10.1016/j.fitote.2009.10.003.
   PubMed Web of Science ®Google Scholar
• Oh S, Rankin AL, Caton AJ. 2010. CD4 + CD25+ regulatory T cells in autoimmune arthritis. Immunol Rev. 233(1):97–111. doi:10.1111/j.0105-2896.2009.
   PubMedGoogle Scholar
• Park JB. 2013. Isolation and quantification of major chlorogenic acids in three major instant coffee brands and their potential effects on H2O2-induced mitochondrial membrane depolarization and apoptosis in PC-12 cells. Food Funct. 4(11):1632–1638. doi:10.1039/c3fo60138b.CQA16.
   PubMed Web of Science ®Google Scholar
• Park JB. 2018. Javamide-II found in coffee is better than caffeine at suppressing TNF-α Production in PMA/PHA-treated lymphocytic Jurkat cells. J Agric Food Chem. 66(26):6782–6789. doi:10.1021/acs.jafc.8b01885.
   PubMed Web of Science ®Google Scholar
• Park JB. 2019. Concurrent detection of javamide-I/-II, 3’-CQA, 4’-CQA, 5’-CQA and caffeine in ground and instant coffees and their comparative quantification and disparity. Sep Sci Plus. 2(7):230–236. doi:10.1002/sscp.201900022.
   Web of Science ®Google Scholar
• Rosenzwajg M, Churlaud G, Hartemann A, Klatzmann D. 2014. Interleukin 2 in the pathogenesis and therapy of type 1 diabetes. Curr Diab Rep. 14(12):553. doi:10.1007/s11892-014-0553-6.
   PubMed Web of Science ®Google Scholar
• Santos RM, Lima DR. 2016. Coffee consumption, obesity and type 2 diabetes: a mini-review. Eur J Nutr. 55(4):1345–1358. doi:10.1007/s00394-016-1206-0.
   PubMed Web of Science ®Google Scholar
• Shevach EM. 2012. Application of IL-2 therapy to target T regulatory cell function. Trends Immunol. 33(12):626–632. doi:10.1016/j.it.2012.07.007.
   PubMed Web of Science ®Google Scholar
• Tsukui A, Santos Júnior HM, Oigman SS, de Souza RO, Bizzo HR, Rezende CM. 2014. Microwave-assisted extraction of green coffee oil and quantification of diterpenes by HPLC. Food Chem. 164(164):266–271. doi:10.1016/j.foodchem.2014.05.039.
   PubMedGoogle Scholar
• Urgert R, Katan MB. 1997. The cholesterol-raising factor from coffee beans. Annu Rev Nutr. 17:305–324. doi:10.1146/annurev.nutr.17.1.305.
   PubMed Web of Science ®Google Scholar
• Yan R, Zhang J, Park HJ, Park ES, Oh S, Zheng H, Junn E, Voronkov M, Stock JB, Mouradian MM. 2018 . Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB. Proc Natl Acad Sci USA. 115(51):E12053–E12062. doi:10.1073/pnas.1813365115.
   PubMed Web of Science ®Google Scholar